Pharma News, Research & Solutions CSR News

Novo Nordisk Publishes Integrated 2018 Annual Report

Article

Novo Nordisk has published its integrated 2018 Annual Report detailing the company’s year-end performance. The report highlights the company’s progression towards long-term targets taking an integrated approach that accounts for financial, social and environmental performance. This is the company’s 15th integrated report.

J&J Exec: Tuberculosis is a Global Emergency. It's Time to Start Treating it That Way

By Paul Stoffels
Summary: 
  • Ebola, and HIV before it, shows what can be accomplished once a disease is catapulted to the top of the global agenda.
     
  • Dr. Paul Stoffels, Johnson & Johnson's chief scientific officer, says tuberculosis is a far deadlier disease, but has not received this sort of attention and focus from the global community.
     
  • An outdated and inadequate toolbox is largely to blame for the unacceptably high toll of TB.
Article
  • Ebola, and HIV before it, shows what can be accomplished once a disease is catapulted to the top of the global agenda.
     
  • Dr. Paul Stoffels, Johnson & Johnson's chief scientific officer, says tuberculosis is a far deadlier disease, but has not received this sort of attention and focus from the global community.
     
  • An outdated and inadequate toolbox is largely to blame for the unacceptably high toll of TB.

Meet a Johnson & Johnson Researcher Poised to Crack the HIV Vaccine Code

In the lead-up to the recent International AIDS Society Conference on HIV Science in the Netherlands, we sat down with Hanneke Schuitemaker, who's hard at work on the holy grail of HIV research: a preventive treatment.
Article

By Sheila Weller

In 1992, as a young HIV/AIDS researcher in her native Netherlands, Hanneke Schuitemaker, Ph.D., now Vice President, Global Head of Viral Vaccine Discovery and Translational Medicine, Janssen Vaccines & Prevention B.V., was devoted to learning as much as she could about the disease—and saw her role as that of a researcher, rather than someone who closely interacted with people who were living with HIV.

But that quickly changed.

Astellas Brings Light to the Lives of Cancer Patients

Blog
At Astellas, we are dedicated to supporting and improving the lives of those impacted by cancer. One of the ways we provide this support is by working with patient advocacy organizations, such as The Leukemia and Lymphoma Society (LLS) – the world's largest voluntary health agency dedicated to blood cancers, including leukemia, lymphoma, Hodgkin's disease and myeloma.
 

Novartis Rises to Second Place in 2018 Access to Medicine Index

Report highlights newly launched Novartis Access Principles to systematically integrate access strategies in research, development and delivery of new medicines
Summary: 

Novartis ranked second in the 2018 Access to Medicine Index (ATMi), up from 3rd place in 2016, in recognition of its long-standing efforts to improve worldwide access to healthcare. Novartis remained the industry leader in access-to-medicine management, and its newly launched Access Principles – which aim to systematically integrate access strategies in how the company researches, develops and delivers medicines globally – have been highlighted as an innovative practice. The Novartis CEO and members of the Executive Committee now also have access objectives as part of their individual objectives.

Press Release

Novartis ranked second in the 2018 Access to Medicine Index (ATMi), up from 3rd place in 2016, in recognition of its long-standing efforts to improve worldwide access to healthcare. Novartis remained the industry leader in access-to-medicine management, and its newly launched Access Principles – which aim to systematically integrate access strategies in how the company researches, develops and delivers medicines globally – have been highlighted as an innovative practice. The Novartis CEO and members of the Executive Committee now also have access objectives as part of their individual objectives.

American Chemical Society Presents Merck with Green Chemistry Challenge Award

Multimedia with summary

We're proud to be named a winner of the American Chemical Society's Green Chemistry Challenge Award. The award recognizes companies for innovative processes in reducing waste and the generation of hazardous materials.

Learn more about our green and sustainable science here: https://bit.ly/2OwNFW7 

Corporate Giving Increased for a Third Consecutive Year, up 15% Since 2015

Industry-leading corporate social investment survey of 252 companies confirms business’ commitment to stakeholder needs
Press Release

NEW YORK, October 30, 2018 /3BL Media/ — In the largest, most robust, industry-leading, and internationally-recognized research of corporate social investment, CECP: The CEO Force for Good, in association with The Conference Board, found in their annual Giving in Numbers: 2018 Edition report that leading corporations are intensifying efforts to meet key societal needs around the world.

Shire Says 'Thank You' to Clinical Research Patient Volunteers

Multimedia with summary

Shire conveys our gratitude to clinical research study participants, very important people who are directly responsible for helping potential new medicines become available to patients in need.

Learn more about Shire’s approach to clinical trials at https://www.shiretrials.com/

Albertsons Companies Pharmacies Release Online Education Tools With Aim to Vaccinate 1.5 Million People This Flu Season

Websites include new flu maps, facts, interactive content for better public understanding
Press Release

BOISE, Idaho, October 9, 2018 /3BL Media/ - To bolster the public’s awareness about flu vaccinations and the fact that many insurance plans will cover most or all of the cost, Albertsons Companies pharmacies have fully revamped their informational consumer flu websites with new features, easier navigation, and interactive tools this flu season.

Merck Announces “Safer Childbirth Cities” Initiative, Issues Call to Action to Reverse the Rise in U.S. Maternal Deaths

Merck for Mothers Commits Additional $10M to Support Locally Created Solutions to Improve Maternal Health and Reduce Disparities
Press Release

KENILWORTH, N.J., October 3 , 2018 /3BL Media/ – Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today a new effort to support cities across the country to help women have a healthy pregnancy and safe childbirth. The “Safer Childbirth Cities” initiative is intended to reduce the number of maternal deaths and life-threatening childbirth events and narrow disparities in maternal health outcomes in the U.S.

Pages

Subscribe to Pharma News, Research & Solutions